METIS innovative logo

METIS innovative

North America, Florida, United States, Miami Beach

Description

METIS innovative is an investment vehicle for promising early stage medical devices and technology in the neurosciences

Investor Profile

METIS innovative has made 4 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (25%)
  • Series B (25%)
  • Seed (25%)
  • Series A (25%)

Country Focus

  • United States (50%)
  • Canada (50%)

Industry Focus

  • Medical
  • Medical Device
  • Computer
  • Information Technology
  • Manufacturing
  • Marketing
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does METIS innovative frequently co-invest with?

Shangbay Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 2
University of Melbourne
Oceania, New South Wales, Australia, Parkville
Co-Investments: 2
ID8 Investments
North America, New York, United States, New York
Co-Investments: 2
General Advance
North America, New York, United States, New York
Co-Investments: 2
Forepont Capital Partners
North America, New York, United States, New York
Co-Investments: 2
Subversive Capital
North America, New York, United States, New York
Co-Investments: 2
NI
North America, California, United States, Palo Alto
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does METIS innovative often collaborate with?

TR
North America, Rhode Island, United States, Providence
Shared Deals: 1
AB
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by METIS innovative?

Fluid Biomed

Calgary, Alberta, Canada

Fluid Biomed is a clinical stage medical device company that develops polymer-based brain stent to cure aneurysms.

Health CareMedicalMedical Device
Series ADec 16, 2024
Amount Raised: $27,000,000
Synchron

Brooklyn, New York, United States

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

ComputerInformation TechnologyManufacturingMarketingMedicalMedical Device
Series CDec 15, 2022
Amount Raised: $75,000,000
Fluid Biomed Inc.

Calgary, Alberta, Canada

Fluid Biomed is a Calgary based company that aims to develop the next generation of stents to improve patient well-being.

Health CareMedicalMedical Device
SeedAug 11, 2021
Amount Raised: $4,700,000
Synchron

Brooklyn, New York, United States

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

ComputerInformation TechnologyManufacturingMarketingMedicalMedical Device
Series BJun 3, 2021
Amount Raised: $40,000,000